Caesarean Delivery
5
1
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
9 treatments under study, led by Classic Group
Research Leaders
8 sponsors active, led by Klinikum Klagenfurt am Wörthersee
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
20%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Regenerative Effects of Birth Material Derived Extracellular Vesicles
Comparison of 'Sip Til Send' Regimens Prior to Elective Caesarean Delivery Using Bedside Gastric Ultrasound
Comparison of Classic and Sequential Spinal Techniques for Preventing Hypotension During Cesarean Delivery.
Comparison of Different Methods of Pain Control After Cesarean Section for Patients on Buprenorphine or Methadone
Subcutaneous Adaption and Cosmetic Outcome Following Caesarean Delivery
Research Network
Common Treatments
- Classic Group1
- The Carbohydrate Group Represent The Interventional Group And Will Utilise The Standard Carbohydraterich Drink1
- Tap Block1
- Ropivacaine1
- Acetaminophen1
Active Sponsors
- Klinikum Klagenfurt am Wörthersee1
- Al-Azhar University1
- Dartmouth-Hitchcock Medical Center1
- Massachusetts General Hospital1
- Brigham and Women's Hospital1
Top Investigators
Klinikum Klagenfurt am Woerthersee and Medical University Vienna
Massachusetts General Hospital
Chair in Translational Neuroscience·BioSciences
Brigham and Women's Hospital
Dartmouth-Hitchcock Medical Center
Related Conditions
- Gastric Emptying1
- Hypotension Postprocedural1
- Pregnancy1